Plunkett Research Online: SignPath Pharma Inc

SIGNPATH PHARMA INC (SGTH:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

SignPath Pharma Inc., is a development stage biotechnology company which focuses on the manufacture and preclinical development of formulations of curcumin, a compound found in the root of the Curcuma longa plant, for applications in malignant diseases......



SignPath Pharma Inc
Ticker: SGTH
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 215 538-9996
Fax: 215 538-1245
Address: 3477 Corporate Parkway
Suite 100
Center Valley, PA 18034 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Lawrence HelsonCEO/Chairman of the Board/Director/President
Jack LevineDirector
See More
SignPath Pharma Inc., is a development stage biotechnology company which focuses on the manufacture and preclinical development of formulations of curcumin, a compound found in the root of the Curcuma longa plant, for applications in malignant diseases......See More See More

Auditor: Friedman LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201520142013201220112010
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: